Stock Analysis on Net
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Total Asset Turnover
since 2005

Microsoft Excel

Calculation

Amgen Inc., total asset turnover, long-term trends, calculation

Microsoft Excel
Total asset turnover = Product sales1 ÷ Total assets1
Dec 31, 2023 0.28 = 26,910 ÷ 97,154
Dec 31, 2022 0.38 = 24,801 ÷ 65,121
Dec 31, 2021 0.40 = 24,297 ÷ 61,165
Dec 31, 2020 0.39 = 24,240 ÷ 62,948
Dec 31, 2019 0.37 = 22,204 ÷ 59,707
Dec 31, 2018 0.34 = 22,533 ÷ 66,416
Dec 31, 2017 0.27 = 21,795 ÷ 79,954
Dec 31, 2016 0.28 = 21,892 ÷ 77,626
Dec 31, 2015 0.29 = 20,944 ÷ 71,576
Dec 31, 2014 0.28 = 19,327 ÷ 69,009
Dec 31, 2013 0.28 = 18,192 ÷ 66,125
Dec 31, 2012 0.31 = 16,639 ÷ 54,298
Dec 31, 2011 0.31 = 15,295 ÷ 48,871
Dec 31, 2010 0.34 = 14,660 ÷ 43,486
Dec 31, 2009 0.36 = 14,351 ÷ 39,629
Dec 31, 2008 0.40 = 14,687 ÷ 36,443
Dec 31, 2007 0.41 = 14,311 ÷ 34,639
Dec 31, 2006 0.41 = 13,858 ÷ 33,788
Dec 31, 2005 0.41 = 12,022 ÷ 29,297

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Amgen Inc., total asset turnover, long-term trends, comparison to competitors

Microsoft Excel
Amgen Inc. AbbVie Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2023 0.28 0.40 0.47 0.28 0.53 0.43 0.51 0.56 0.36 0.26 0.40 0.43
Dec 31, 2022 0.38 0.42 0.48 0.37 0.58 0.43 0.51 0.54 0.71 0.51 0.42 0.46
Dec 31, 2021 0.40 0.38 0.42 0.35 0.58 0.40 0.52 0.46 0.72 0.45 0.63 0.41
Dec 31, 2020 0.39 0.30 0.36 0.29 0.53 0.36 0.47 0.52 0.03 0.27 0.50 0.47
Dec 31, 2019 0.37 0.37 0.20 0.29 0.57 0.36 0.52 0.55 0.00 0.31 0.53 0.44
Dec 31, 2018 0.34 0.55 0.64 0.42 0.56 0.34 0.53 0.51 0.00 0.34 0.57 0.43
Dec 31, 2017 0.27 0.40 0.62 0.39 0.51 0.37 0.49 0.46 — 0.31 0.67 0.37
Dec 31, 2016 0.28 0.39 0.58 0.37 0.55 0.53 0.51 0.42 — 0.31 0.70 0.40
Dec 31, 2015 0.29 0.43 0.52 0.43 0.56 0.62 0.53 0.39 — 0.29 0.73 0.41
Dec 31, 2014 0.28 0.72 0.47 0.54 0.53 0.71 0.57 0.43 — 0.29 0.73 0.39
Dec 31, 2013 0.28 0.64 0.42 0.55 0.66 0.48 0.54 0.42 — 0.30 0.71 0.41
Dec 31, 2012 0.31 0.68 0.49 0.55 0.66 0.44 0.55 0.45 — 0.32 0.66 0.46
Dec 31, 2011 0.31 — 0.64 0.54 0.72 0.47 0.57 0.46 — 0.36 0.34 0.44
Dec 31, 2010 0.34 — 0.63 0.59 0.74 0.64 0.60 0.43 — 0.35 0.42 0.51
Dec 31, 2009 0.36 — 0.61 0.57 0.80 0.67 0.65 0.24 — 0.23 0.51 0.47
Dec 31, 2008 0.40 — 0.70 0.73 0.70 0.72 0.75 0.51 — 0.43 0.36 0.50
Dec 31, 2007 0.41 — 0.74 0.63 0.70 0.64 0.75 0.50 — 0.42 0.13 0.46
Dec 31, 2006 0.41 — 0.70 0.75 0.71 0.63 0.76 0.51 — 0.42 0.11 0.18
Dec 31, 2005 0.41 — 0.68 0.87 0.60 0.48 0.87 0.49 — 0.44 0.16 0.62

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Amgen Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Amgen Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2023 0.28 0.40
Dec 31, 2022 0.38 0.48
Dec 31, 2021 0.40 0.45
Dec 31, 2020 0.39 0.38
Dec 31, 2019 0.37 0.39
Dec 31, 2018 0.34 0.45
Dec 31, 2017 0.27 0.40
Dec 31, 2016 0.28 0.41
Dec 31, 2015 0.29 0.42
Dec 31, 2014 0.28 0.45
Dec 31, 2013 0.28 0.43
Dec 31, 2012 0.31 0.45
Dec 31, 2011 0.31 0.46
Dec 31, 2010 0.34 0.47
Dec 31, 2009 0.36 0.39
Dec 31, 2008 0.40 0.57
Dec 31, 2007 0.41 0.56
Dec 31, 2006 0.41 0.54
Dec 31, 2005 0.41 0.57

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Amgen Inc., total asset turnover, long-term trends, comparison to industry (health care)

Microsoft Excel
Amgen Inc. Health Care
Dec 31, 2023 0.28 0.80
Dec 31, 2022 0.38 0.81
Dec 31, 2021 0.40 0.76
Dec 31, 2020 0.39 0.70
Dec 31, 2019 0.37 0.71
Dec 31, 2018 0.34 0.67
Dec 31, 2017 0.27 0.68
Dec 31, 2016 0.28 0.70
Dec 31, 2015 0.29 0.67
Dec 31, 2014 0.28 0.72
Dec 31, 2013 0.28 0.69
Dec 31, 2012 0.31 0.69
Dec 31, 2011 0.31 0.70
Dec 31, 2010 0.34 0.69
Dec 31, 2009 0.36 0.64
Dec 31, 2008 0.40 0.81
Dec 31, 2007 0.41 0.77
Dec 31, 2006 0.41 0.74
Dec 31, 2005 0.41 0.70

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).